Lv31
358 积分 2024-09-23 加入
Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease: A Meta-Analysis of Patient-Level Data
8小时前
已完结
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
8小时前
已完结
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
9小时前
已完结
The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes
4天前
已完结
REVEAL-CKD: prevalence of undiagnosed stage 3 chronic kidney disease in Australia, Brazil, Canada and Spain
6天前
已完结
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection
11天前
已完结
[The aldosterone antagonist spironolactone prolongs the survival of chronic heart failure patients. The results of the RALES study. The Randomized Aldactone Evaluation Study]
12天前
已关闭
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group
12天前
已完结
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
12天前
已完结
Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial
12天前
已完结
皖公网安备34019202002308
